Atlas Trials

Immunotherapy Treating GI Cancer

Clinical trial NCT03614650 · RECRUITING

Trial details

NCT number
NCT03614650
Sponsor
Shenzhen Geno-Immune Medical Institute
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2025-07-01
Primary completion
2028-06-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.